Last reviewed · How we verify
cefuroxime pivoxetil
cefuroxime pivoxetil is a Cephalosporin Antibacterial drug. It is currently in unknown development.
Cefuroxime pivoxetil works by inhibiting the bacterial enzyme responsible for cell wall synthesis, ultimately leading to bacterial cell death.
Cefuroxime pivoxetil is a small molecule antibiotic. It is also known by the synonyms CCI 23628, CCI-23628, and CEFUROXIME PIVOXETIL.
At a glance
| Generic name | cefuroxime pivoxetil |
|---|---|
| Drug class | Cephalosporin Antibacterial |
| Therapeutic area | Infectious Disease |
| Phase | unknown |
Mechanism of action
Imagine your body's cells are like houses, and the bacterial cell wall is like the foundation. Cefuroxime pivoxetil blocks the construction of this foundation, making it impossible for the bacteria to build a strong wall and ultimately leading to their death.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- cefuroxime pivoxetil CI brief — competitive landscape report
- cefuroxime pivoxetil updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about cefuroxime pivoxetil
What is cefuroxime pivoxetil?
How does cefuroxime pivoxetil work?
What drug class is cefuroxime pivoxetil in?
What development phase is cefuroxime pivoxetil in?
Related
- Drug class: All Cephalosporin Antibacterial drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Infectious Disease
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing